households include a GLP-1 user, implying these emerging food preferences are impacting about one out of every four consumers
There is no one size fits all answer, as your medical history, BMI, and lifestyle all play a role
At TrimRx, we strictly partner with pharmacies that meet these rigorous safety and quality standards
Stougaard EB, Rossing P, Vistisen D et al (2023) Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and kidney disease as assessed by Steno T1 Risk Engine in adults with type 1 diabetes
00:10:27 Vickie Danaher But studies suggest that there may be a somewhat higher discontinuation rate with orforglipron compared with oral semaglutide, potentially due to these GI side effects